Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allarity Therapeutics (ALLR) Other Operating Expenses (2024)

Allarity Therapeutics' Other Operating Expenses history spans 1 years, with the latest figure at $9.7 million for Q3 2024.

  • For Q3 2024, Other Operating Expenses changed N/A year-over-year to $9.7 million; the TTM value through Jun 2025 reached $9.7 million, changed N/A, while the annual FY2024 figure was $9.7 million, N/A changed from the prior year.
  • Other Operating Expenses reached $9.7 million in Q3 2024 per ALLR's latest filing.
  • In the past five years, Other Operating Expenses ranged from a high of $9.7 million in Q3 2024 to a low of $9.7 million in Q3 2024.